Free Trial
Your $100 Credit Expires Tomorrow! Get MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Andre Salles Analyst Performance

Analyst at UBS Group

Andre Salles is a stock analyst at UBS Group focused in the consumer discretionary sector, covering 3 publicly traded companies. Over the past year, Andre Salles has issued 12 stock ratings, including buy and hold recommendations. While full access to Andre Salles' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andre Salles' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 0 Years
Buy Recommendations
66.67% 8 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%8 ratings
Hold33.3%4 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Andre Salles at UBS Group, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

Andre Salles, an analyst at UBS Group, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Consumer Discretionary
2 companies
66.7%
Medical
1 company
33.3%

Andre Salles of UBS Group specializes in stock coverage within the Consumer Discretionary sector, with additional focus on Medical companies.

Coverage Industries

IndustryPercentage
SCHOOLS
2 companies
66.7%
MED INSTRUMENTS
1 company
33.3%

Andre Salles' Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Laureate Education stock logo
LAUR
Laureate Education
5/1/2026Boost Price Target$30.53$39.00Buy
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
3/17/2026Lower Price Target$486.22$550.00Neutral
Laureate Education stock logo
LAUR
Laureate Education
2/24/2026Reiterated Rating$33.16Buy
Laureate Education stock logo
LAUR
Laureate Education
2/24/2026Lower Price Target$33.36$37.50Buy
Afya Limited stock logo
AFYA
Afya
1/16/2026Reiterated Rating$14.39$16.00Neutral
Afya Limited stock logo
AFYA
Afya
1/16/2026Downgrade$13.93$16.00Neutral
Afya Limited stock logo
AFYA
Afya
1/8/2026Lower Price Target$15.02$18.00Buy
Laureate Education stock logo
LAUR
Laureate Education
1/8/2026Boost Price Target$34.55$39.00Buy
Laureate Education stock logo
LAUR
Laureate Education
11/3/2025Boost Price Target$29.28$36.00Buy
Laureate Education stock logo
LAUR
Laureate Education
9/19/2025Initiated Coverage$29.61$35.00Buy
Afya Limited stock logo
AFYA
Afya
9/8/2025Upgrade$15.04$19.00Buy
Afya Limited stock logo
AFYA
Afya
6/12/2025Reiterated Rating$17.99$19.50Neutral